Veracyte | VCYT - 流动资产

金融业

USD 44.39

USD 1.49B

现金及等价物

USD 299.52M

USD 42.19M

USD 574.78M

USD 62.74M

USD 39.33M

USD 23.96M

USD 43.96M

824

EPS每股收益

USD 0.54

股本和储备

USD 1.39B

USD 108.55M

债务利息支出

USD 2K

USD 3.48M

USD 0

USD 3.55B

USD 25.49M

USD 126.36M

USD 23.96M

普通股股本

USD 79.79M

42.77

USD 26.52M

USD 150.32M

销售和管理费用

USD 55.71M

USD 22.66M

贸易债权人

USD 8.02M

应收帐款人

USD 54.18M

	流动资产	更改		日
Agenus	USD 78.81M		16.47M	2026-06
Agilent	USD 4.69B		70M	2026-06
Anika Therapeutics	USD 99.19M		5.63M	2026-06
Arrowhead Research	USD 1.67B		168.34M	2026-06
Bruker	USD 2.22B		121.4M	2026-06
Heron Therapeutics	USD 229.84M		861K	2026-06
Illumina	USD 2.83B		96M	2026-06
Intrexon	USD 23.72M		45.04M	2024-06
Karyopharm Therapeutics	USD 126.33M		23.19M	2026-03
Laboratory Of America	USD 3.81B		743.9M	2026-06
Ligand Pharmaceuticals	USD 1.46B		591.7M	2026-06
Myriad Genetics	USD 289M		23.8M	2026-06
Rigel Pharmaceuticals	USD 214.93M		39.53M	2025-09
Roche Holding	CHF 35.44B		3.29B	2026-06
Sangamo BioSciences	USD 49.89M		12.3M	2025-06
Siemens	EUR 65.14B		3.81B	2026-06
Sonic Healthcare	AUD 2.3B		52.76M	2024-12
Thermo Fisher Scientific	USD 23.36B		1.05B	2026-06
Veracyte	USD 574.78M		52.6M	2026-06
Waters	USD 3.9B		186M	2026-06